Pars Plana Surgical Capsulotomy for Posterior Capsular Opacification

This study has been completed.
Sponsor:
Collaborator:
Pakistan Ministry of Health
Information provided by:
Dow University of Health Sciences
ClinicalTrials.gov Identifier:
NCT00964613
First received: August 24, 2009
Last updated: NA
Last verified: August 2009
History: No changes posted
  Purpose

Cataract is a leading cause of Global blindness. After cataract surgery nearly half of the people become blind due to posterior capsular opacification. The only solution for this problem is LASER capsulotomy. Laser machine is not available in remote areas especially in underdeveloped countries. The solution of this problem is surgical capsulotomy which can be performed any where.


Condition
Blindness

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Pars Plana Surgical Capsulotomy for Posterior Capsular Opacification

Further study details as provided by Dow University of Health Sciences:

Enrollment: 176
Study Start Date: January 2008
Study Completion Date: January 2009
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Detailed Description:

posterior capsular opacification is treated by YAG laser capsulotomy. this require sophisticated technology ans specific environment which is not possible in underdeveloped countries. we describe a method in which posterior capsular opacification could be managed by using only a 27 Gauge needle through pars plana. opacified posterior capsule is under tension that is why a small puncture results in a large central opening

  Eligibility

Ages Eligible for Study:   1 Year to 95 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients having posterior capsular opacification

Criteria

Inclusion Criteria:

  • Patients with Posterior capsular opacification
  • Both Sexes
  • All ages

Exclusion Criteria:

  • Retinal disease
  • Uncontrolled Glaucoma
  • Corneal opacity
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Dr. Shahid Wahab, Professor of Ophthalmology, Dow University of Health Sciences, Karachio, Pakistan
ClinicalTrials.gov Identifier: NCT00964613     History of Changes
Other Study ID Numbers: Surgical Capsulotomy
Study First Received: August 24, 2009
Last Updated: August 24, 2009
Health Authority: Pakistan: Research Ethics Committee

Keywords provided by Dow University of Health Sciences:
Pars Plana
Surgical Capsulotomy
Posterior capsule opacification
visual outcome
Complications

ClinicalTrials.gov processed this record on October 16, 2014